Literature DB >> 25457617

Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye.

Abdoulaye Sene1, David Chin-Yee2, Rajendra S Apte3.   

Abstract

The central role of vascular endothelial growth factor (VEGF) signaling in regulating normal vascular development and pathological angiogenesis has been documented in multiple studies. Ocular anti-VEGF therapy is highly effective for treating a subset of patients with blinding eye disorders such as diabetic retinopathy and neovascular age-related macular degeneration (AMD). However, chronic VEGF suppression can lead to adverse effects associated with poor visual outcomes due to the loss of prosurvival and neurotrophic capacities of VEGF. In this review, we discuss emerging evidence for immune-related mechanisms that regulate ocular angiogenesis in a VEGF-independent manner. These novel molecular and cellular pathways may provide potential therapeutic avenues for a multitarget strategy, preserving the neuroprotective functions of VEGF in those patients whose disease is unresponsive to VEGF neutralization.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  age-related macular degeneration (AMD); angiogenesis; diabetic retinopathy; immune regulation; neovascularization; vascular endothelial growth factor (VEGF)

Mesh：

Substances：

Year:  2014        PMID： 25457617      PMCID： PMC4282831          DOI： 10.1016/j.molmed.2014.10.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN： 1471-4914            Impact factor:   11.951


  97 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  Angiogenic pathways in diabetic retinopathy.

Authors:  Lloyd Paul Aiello
Journal:  N Engl J Med       Date:  2005-08-25       Impact factor: 91.245

3.  Fibroblastic Overgrowth of Persistent Tunica Vasculosa Lentis in Infants Born Prematurely: II. Report of Cases-Clinical Aspects.

Authors:  T L Terry
Journal:  Trans Am Ophthalmol Soc       Date:  1942

Review 4.  Immune responses in age-related macular degeneration and a possible long-term therapeutic strategy for prevention.

Authors:  Robert B Nussenblatt; Richard W J Lee; Emily Chew; Lai Wei; Baoying Liu; H Nida Sen; Andrew D Dick; Frederick L Ferris
Journal:  Am J Ophthalmol       Date:  2014-04-04       Impact factor: 5.258

5.  Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

Authors:  David M Brown; Peter A Campochiaro; Rishi P Singh; Zhengrong Li; Sarah Gray; Namrata Saroj; Amy Chen Rundle; Roman G Rubio; Wendy Yee Murahashi
Journal:  Ophthalmology       Date:  2010-04-09       Impact factor: 12.079

6.  Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function.

Authors:  Alexander G Marneros; Jie Fan; Yoshihito Yokoyama; Hans Peter Gerber; Napoleone Ferrara; Rosalie K Crouch; Bjorn R Olsen
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

7.  Hypomethylation of the IL17RC promoter associates with age-related macular degeneration.

Authors:  Lai Wei; Baoying Liu; Jingsheng Tuo; Defen Shen; Ping Chen; Zhiyu Li; Xunxian Liu; Jia Ni; Pradeep Dagur; H Nida Sen; Shayma Jawad; Diamond Ling; Stanley Park; Sagarika Chakrabarty; Catherine Meyerle; Elvira Agron; Frederick L Ferris; Emily Y Chew; J Philip McCoy; Emily Blum; Peter J Francis; Michael L Klein; Robyn H Guymer; Paul N Baird; Chi-Chao Chan; Robert B Nussenblatt
Journal:  Cell Rep       Date:  2012-11-21       Impact factor: 9.423

Review 8.  Emerging therapies for neovascular age-related macular degeneration: drugs in the pipeline.

Authors:  Peter K Kaiser
Journal:  Ophthalmology       Date:  2013-05       Impact factor: 12.079

9.  Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

Authors:  Jeffrey S Heier; David M Brown; Victor Chong; Jean-Francois Korobelnik; Peter K Kaiser; Quan Dong Nguyen; Bernd Kirchhof; Allen Ho; Yuichiro Ogura; George D Yancopoulos; Neil Stahl; Robert Vitti; Alyson J Berliner; Yuhwen Soo; Majid Anderesi; Georg Groetzbach; Bernd Sommerauer; Rupert Sandbrink; Christian Simader; Ursula Schmidt-Erfurth
Journal:  Ophthalmology       Date:  2012-10-17       Impact factor: 12.079

Review 10.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03
View more
  49 in total

Review 1.  Animal models of ocular angiogenesis: from development to pathologies.

Authors:  Chi-Hsiu Liu; Zhongxiao Wang; Ye Sun; Jing Chen
Journal:  FASEB J       Date:  2017-07-24       Impact factor: 5.191

2.  HIF-2α, acting via miR-191, is involved in angiogenesis and metastasis of arsenite-transformed HBE cells.

Authors:  Wenchao Xu; Fei Luo; Baofei Sun; Hua Ye; Jun Li; Le Shi; Yi Liu; Xiaolin Lu; Bairu Wang; Qingling Wang; Qizhan Liu; Aihua Zhang
Journal:  Toxicol Res (Camb)       Date:  2015-11-06       Impact factor: 3.524

3.  FGF2-induced STAT3 activation regulates pathologic neovascularization.

Authors:  Zhenyu Dong; Andrea Santeford; Norimitsu Ban; Tae Jun Lee; Craig Smith; David M Ornitz; Rajendra S Apte
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

Review 4.  VEGF in Signaling and Disease: Beyond Discovery and Development.

Authors:  Rajendra S Apte; Daniel S Chen; Napoleone Ferrara
Journal:  Cell       Date:  2019-03-07       Impact factor: 41.582

5.  siRNA Therapeutics in Ocular Diseases.

Authors:  Javier Moreno-Montañés; Anne-Marie Bleau; Tamara Martínez; Beatriz Vargas; María Victoria González; Ana Isabel Jiménez
Journal:  Methods Mol Biol       Date:  2021

6.  Nicotine increased VEGF and MMP2 levels in the rat eye and kidney.

Authors:  Mehmet Ates; Ferda Hosgorler; Oguz Yuksel; Sultan Kaya Unsal; Guven Guvendi; Asli Karakilic; Basar Koc; Sevim Kandis; Lutfiye Kanit; Nazan Uysal
Journal:  Environ Sci Pollut Res Int       Date:  2019-10-02       Impact factor: 4.223

7.  Thrombospondin-1-Based Antiangiogenic Therapy.

Authors:  Jennifer N Sims; Jack Lawler
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-03       Impact factor: 2.671

8.  Critical role of caveolin-1 in ocular neovascularization and multitargeted antiangiogenic effects of cavtratin via JNK.

Authors:  Yida Jiang; Xianchai Lin; Zhongshu Tang; Chunsik Lee; Geng Tian; Yuxiang Du; Xiangke Yin; Xiangrong Ren; Lijuan Huang; Zhimin Ye; Wei Chen; Fan Zhang; Jia Mi; Zhiqin Gao; Shasha Wang; Qishan Chen; Liying Xing; Bin Wang; Yihai Cao; William C Sessa; Rong Ju; Yizhi Liu; Xuri Li
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

Review 9.  NAD+ and sirtuins in retinal degenerative diseases: A look at future therapies.

Authors:  Jonathan B Lin; Rajendra S Apte
Journal:  Prog Retin Eye Res       Date:  2018-06-12       Impact factor: 21.198

10.  Macrophage microRNA-150 promotes pathological angiogenesis as seen in age-related macular degeneration.

Authors:  Jonathan B Lin; Harsh V Moolani; Abdoulaye Sene; Rohini Sidhu; Pamela Kell; Joseph B Lin; Zhenyu Dong; Norimitsu Ban; Daniel S Ory; Rajendra S Apte
Journal:  JCI Insight       Date:  2018-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.